ES2112600T3 - Procedimiento para la preparacion de tabletas que contienen molsidomina. - Google Patents

Procedimiento para la preparacion de tabletas que contienen molsidomina.

Info

Publication number
ES2112600T3
ES2112600T3 ES95118031T ES95118031T ES2112600T3 ES 2112600 T3 ES2112600 T3 ES 2112600T3 ES 95118031 T ES95118031 T ES 95118031T ES 95118031 T ES95118031 T ES 95118031T ES 2112600 T3 ES2112600 T3 ES 2112600T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
tablets containing
molsidomine
containing molsidomine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95118031T
Other languages
English (en)
Inventor
Dieter Dr Voegele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2112600T3 publication Critical patent/ES2112600T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCESO PARA LA ELABORACION DE TABLETAS DE RETARDO QUE CONTIENEN MOLSIDOMINA, CARACTERIZANDOSE DE TAL MODO QUE LA MOLSIDOMINA SE MEZCLA CON UN GRANULADO PORTADOR LIBRE DE SUSTANCIA ACTIVA Y A CONTINUACION SE PRESIONA PARA LA OBTENCION DE TABLETAS.
ES95118031T 1994-12-03 1995-11-16 Procedimiento para la preparacion de tabletas que contienen molsidomina. Expired - Lifetime ES2112600T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4443105A DE4443105C2 (de) 1994-12-03 1994-12-03 Verfahren zur Herstellung Molsidomin-haltiger Tabletten

Publications (1)

Publication Number Publication Date
ES2112600T3 true ES2112600T3 (es) 1998-04-01

Family

ID=6534858

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95118031T Expired - Lifetime ES2112600T3 (es) 1994-12-03 1995-11-16 Procedimiento para la preparacion de tabletas que contienen molsidomina.

Country Status (4)

Country Link
EP (1) EP0714661B1 (es)
AT (1) ATE163129T1 (es)
DE (2) DE4443105C2 (es)
ES (1) ES2112600T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US9901540B2 (en) 2010-05-10 2018-02-27 Euro-Celtique S.A. Combination of active loaded granules with additional actives
CN102946870A (zh) 2010-05-10 2013-02-27 欧洲凯尔特公司 包含氢吗啡酮和纳洛酮的药物组合物
EP2568968B1 (en) * 2010-05-10 2017-07-12 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
BE1028879B1 (fr) * 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346638A1 (de) * 1983-12-23 1985-07-04 Cassella Ag, 6000 Frankfurt Photostabilisierung von molsidomin
DE4315664C2 (de) * 1993-05-11 1995-10-12 Cassella Ag Galenische Zubereitungen von Molsidomin
ATE185273T1 (de) * 1993-05-11 1999-10-15 Hoechst Ag Galenische zubereitungen von molsidomin

Also Published As

Publication number Publication date
ATE163129T1 (de) 1998-02-15
DE4443105A1 (de) 1996-06-05
DE59501443D1 (de) 1998-03-19
DE4443105C2 (de) 1997-03-13
EP0714661A1 (de) 1996-06-05
EP0714661B1 (de) 1998-02-11

Similar Documents

Publication Publication Date Title
ATE69141T1 (de) Nikotin enthaltende tablette.
DE3374314D1 (en) Total synthesis of antitumor antibiotics
AU6542286A (en) Pressure-sensitive adhesive containing heat-sensitive materials
DK0767830T3 (da) Fremstilling af et flerenzymgranulat
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
ES2112600T3 (es) Procedimiento para la preparacion de tabletas que contienen molsidomina.
DE58901906D1 (de) Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz.
PT545511E (pt) Processo para a preparacao de tetraazamacrociclos mono-n-substituidos
ATE103594T1 (de) Fucosidase-inhibitoren.
US5077480B1 (en) Transmissometer having solid state light source
SE8500845L (sv) Forfarande for framstellning av glyoxylylspermidin och anvendningen derav for framstellning av 15-deoxispergualin-beslektade foreningar
GB8918638D0 (en) Assembled module of brake booster and pedal
DE58906241D1 (de) Verwendung von Plasminogen-Aktivator-Inhibitor (PAI-2) zur Immunsuppression.
AU7186487A (en) Use of D. bardawil as a source of vitamin A and a yolk-color enhancing agent
ES552013A0 (es) Procedimiento para preparar perborato de sodio
ES2089661T3 (es) Soluciones para inyeccion de mesna.
ES2071653T3 (es) Procedimiento para preparar beta-2',2'-difluornucleosidos.
AU7025087A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
MX9302878A (es) Procedimiento para la preparacion de un diaminodiol substituido.
ES2195378T3 (es) Procedimiento para la sintesis de taxanos.
MX9201191A (es) Productos que contienen verapamil y trandolapril
DK119388D0 (da) Middel indeholdende bacillus polymyxa til indgivelse til dyr
GR3018763T3 (en) Element for assay of catechol and catechol generating substances.
GB8918634D0 (en) Assembled module of brake booster and pedal
DK585486D0 (da) Polerguldpraeparat

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 714661

Country of ref document: ES